Minerva FDA

3 stories · following the connections

Business

Minerva Provides Update on Phase 3 Design and Development Strategy for MIN-101

By Nasdaq OMXMay 15, 2017, 12:15 PM UTC

Business

Minerva Announces Outcome of End-of-Phase 2 Meeting With FDA

By Nasdaq OMXMay 15, 2017, 12:01 PM UTC

Business

Minerva Announces Outcome of End-of-Phase 2 Meeting With FDA

By Nasdaq OMXMay 15, 2017, 12:01 PM UTC